ACA App
Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia Annals of Cardiac Anaesthesia
Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Submission | Subscribe | Advertise | Contact | Login 
Users online: 170 Small font size Default font size Increase font size Print this article Email this article Bookmark this page
Read this article

 


    Article Cited by others

REVIEW ARTICLE

Current status of bosentan for treatment of pulmonary hypertension

Raja Shahzad G, Dreyfus Gilles D

Year : 2008| Volume: 11| Issue : 1 | Page no: 6-14

   This article has been cited by
 
1 Cerebrovascular disease in ageing and Alzheimerís disease
Seth Love,J. Scott Miners
Acta Neuropathologica. 2015;
[Pubmed]  [Google Scholar] [DOI]
2 Succinct Synthesis of Bosentan Utilizing Glycol Mono-THP Ether
Chung Ryul Lee,Sang Yeul Lee,Tae-gyu Nam
Synthetic Communications. 2014; 44(17): 2488
[Pubmed]  [Google Scholar] [DOI]
3 Integrated pharmacokinetics and pharmacodynamics of epoprostenol in healthy subjects
Laurent B. Nicolas,Andreas Krause,Marcelo M. Gutierrez,Jasper Dingemanse
British Journal of Clinical Pharmacology. 2012; 74(6): 978
[Pubmed]  [Google Scholar] [DOI]
4 Integrated pharmacokinetics and pharmacodynamics of epoprostenol in healthy subjects
Nicolas, L.B. and Krause, A. and Gutierrez, M.M. and Dingemanse, J.
British Journal of Clinical Pharmacology. 2012; 74(6): 978-989
[Pubmed]  [Google Scholar]
5 Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension
Raja, S.G.
Recent Patents on Cardiovascular Drug Discovery. 2012; 7(2): 100-104
[Pubmed]  [Google Scholar]
6 Treating pulmonary arterial hypertension: Current treatments and future prospects
Raja, S.G. and Raja, S.M.
Therapeutic Advances in Chronic Disease. 2011; 2(6): 359-370
[Pubmed]  [Google Scholar]
7 Review of the guidelines for the treatment of pulmonary arterial hypertension in children [Revisão Das Diretrizes De Tratamento Da Hipertensão Arterial Pulmonar Na População Pediátrica]
Banjar, H.H.
PVRI Review. 2011; 3(3): 12-25
[Pubmed]  [Google Scholar]
8 Endothelin receptor antagonists for pulmonary arterial hypertension
Raja, S.G.
Cardiovascular Therapeutics. 2010; 28(5): e65-e71
[Pubmed]  [Google Scholar]
9 Perioperative management of pulmonary hypertension
Tempe, D.K.
Annals of Cardiac Anaesthesia. 2010; 13(2): 89-91
[Pubmed]  [Google Scholar]
10 Post-operative management of endarterectomy
Wiwanitkit, V.
Annals of Cardiac Anaesthesia. 2010; 13(3): 264
[Pubmed]  [Google Scholar]
11 REVIEW: Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: An Overview : ERAs for PAH
Shahzad G. Raja
Cardiovascular Therapeutics. 2010; 28(5): e65
[HTML Full text]  [Google Scholar] [DOI]
12 Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease
Dimitrijevic, I., Edvinsson, M.-L., Chen, Q., MalmsjŲ, M., Kimblad, P.-O., Edvinsson, L.
BMC Cardiovascular Disorders. 2009; 9: 40
[Pubmed]  [Google Scholar]
13 Therapeutic targets in pulmonary arterial hypertension
Christopher J. Rhodes,Alexandra Davidson,J. Simon R. Gibbs,John Wharton,Martin R. Wilkins
Pharmacology & Therapeutics. 2009; 121(1): 69
[Pubmed]  [Google Scholar] [DOI]
14 Therapeutic targets in pulmonary arterial hypertension
Rhodes, C.J., Davidson, A., Gibbs, J.S.R., Wharton, J., Wilkins, M.R.
Pharmacology and Therapeutics. 2009; 121(1): 69-88
[Pubmed]  [Google Scholar]
15 Increased expression of vascular endothelin type B and angiotensin type 1 receptors in patients with ischemic heart disease
Ivan Dimitrijevic,Marie-Louise Edvinsson,Qingwen Chen,Malin MalmsjŲ,Per-Ola Kimblad,Lars Edvinsson
BMC Cardiovascular Disorders. 2009; 9(1)
[Pubmed]  [Google Scholar] [DOI]
16 Hidden hazards of Bosentan therapy in pulmonary hypertension
Sethi, S. and Sethi, R. and Wareham, C.
surgery. 2008; 11: 15-9
[Pubmed]  [Google Scholar]
17 Roles of Oxidants, Nitric Oxide, and Asymmetric Dimethylarginine in Endothelial Function
Siekmeier, R. and Grammer, T. and Marz, W.
Journal of Cardiovascular Pharmacology and Therapeutics. 2008; 13(4): 279-297
[Pubmed]  [Google Scholar]
18 Bosentan for the treatment of portopulmonary hypertension.
Tempe, DK and Datt, V. and Datta, D.
Annals of cardiac anaesthesia. ; 11(2): 139
[Pubmed]  [Google Scholar]